Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › pheochromocytoma

Pheochromocytoma

Part of Germ cell tumors

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for pheochromocytoma

7 trials tracked for pheochromocytoma: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 183 citations.

7Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 6
  1. Phase 3 Preoperative Alpha Blockade for Pheochromocytoma Completed · 183 cited
  2. Phase 2 Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study Completed
  3. Phase 2 Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma Completed
  4. Phase 2 A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors Completed
  5. Phase 2 A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... Completed
  6. Phase 2 Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma Completed
Show 1 more trials
  1. Phase 2 Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Pheochromocytoma misdiagnosed as allergic vasculitis in a 36-year-old male led to ulcer healing but required toe amputation
Diabetes & Endocrinology Sys. Review
Pheochromocytoma misdiagnosed as allergic vasculitis in a 36-year-old male led to ulcer healing but required toe amputation 24 Years of Leg Ulcers Led Back to a Hidden Tumor
This case report describes a 36-year-old male with pheochromocytoma initially misdiagnosed as allergic vasculitis.
A man's 24-year leg ulcer mystery ended when a hidden adrenal tumor was found, proving the wrong diagnosis kept his wounds from healing.
Frontiers Apr 13, 2026